Sporothrix schenckiisensitivity to voriconazole, itraconazole and amphotericin B
Open Access
- 1 January 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 39 (4) , 369-371
- https://doi.org/10.1080/mmy.39.4.369.371
Abstract
One hundred clinical isolates of Sporothrix schenckii were tested against voriconazole, itraconazole and amphotericin B using a modification of the NCCLS M27-A in vitro yeast susceptibility testing procedure. NCCLS M38-P for moulds was not used because yeast forms may have been present when the test isolates were incubated at 35 ± 1°C. The minimum inhibitory concentration (MIC) values were: voriconazole 0·5–8 (geometric mean titer 6·50) µg ml-1; itraconazole 0·03–8 (geometric mean titer 1·56) µg ml-1; and amphotericin B 0·25–2 (geometric mean titer 1·23) µg ml-1. The minimum fungicidal concentration (MFC) values were: voriconazole 2–8 (geometric mean titer 7·67) µg ml-1; itraconazole 0·125–8 (geometric mean titer 7·41) µg ml-1; and amphotericin B 0·125–2 (geometric mean titer 1·53) µg ml-1. Based upon MIC values, sensitivity to amphotericin B is strain-dependent. S. schenckii is more sensitive to itraconazole than voriconazole based upon a comparison of MIC geometric means, even though the MIC ranges were essentially the same.Keywords
This publication has 3 references indexed in Scilit:
- In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold PathogensAntimicrobial Agents and Chemotherapy, 1999
- Endemic mycoses: a treatment updateJournal of Antimicrobial Chemotherapy, 1999
- In vitro evaluation of voriconazole against some clinically important fungiAntimicrobial Agents and Chemotherapy, 1997